Search

Your search keyword '"Trouillet‐Assant, Sophie"' showing total 295 results

Search Constraints

Start Over You searched for: Author "Trouillet‐Assant, Sophie" Remove constraint Author: "Trouillet‐Assant, Sophie"
295 results on '"Trouillet‐Assant, Sophie"'

Search Results

2. Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion

3. Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs

4. Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency.

5. Safety of baricitinib in vaccinated patients with severe and critical COVID-19 sub study of the randomised Bari-SolidAct trial

7. Advancing respiratory virus diagnostics: integrating the nasal IFN-I score for improved viral detection

8. Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency

9. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

12. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

13. The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

14. Inherited and acquired errors of type I interferon immunity govern susceptibility to COVID-19 and multisystem inflammatory syndrome in children

15. Virological and clinical features of acute respiratory failure associated with covid-19 in pregnancy: A case-control study

17. Immunogenicity and efficacy of          heterologous ChAdOx1–BNT162b2 vaccination

18. Refining “Long-COVID” by a Prospective Multimodal Evaluation of Patients with Long-Term Symptoms Attributed to SARS-CoV-2 Infection

20. Exploring viral respiratory coinfections: Shedding light on pathogen interactions.

21. Évaluer la réponse immunitaire cellulaire de l'hôte pour mieux prévenir et diagnostiquer les infections virales.

23. Assessment of serological techniques for screening patients for COVID-19 (COVID-SER): a prospective, multicentric study

24. Pre–Covid-19, SARS-CoV-2–Negative Multisystem Inflammatory Syndrome in Children

26. Performance of 11 Host Biomarkers Alone or in Combination in the Diagnosis of Late-Onset Sepsis in Hospitalized Neonates: The Prospective EMERAUDE Study

29. Inherited and acquired errors of type I interferon immunity govern susceptibility to COVID-19 and multisystem inflammatory syndrome in children

30. Prior SARS-CoV-2 infection enhances and reshapes spike protein–specific memory induced by vaccination

31. A third vaccine dose equalises the levels of effectiveness and immunogenicity of heterologous or homologous COVID-19 vaccine regimens, Lyon, France, December 2021 to March 2022

32. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

33. A third vaccine dose equalizes the levels of effectiveness and immunogenicity of heterologous or homologous COVID-19 vaccine regimens

34. Determinants of protection against SARS-CoV-2 Omicron BA.1 and Delta infections in fully vaccinated outpatients

35. Towards a Universal Marker of Ongoing Respiratory Viral Infections Based on Nasal Host Response

36. COVID-19 pandemic-associated chilblains: more links for SARS-CoV-2 and less evidence for high interferon type I systemic response

38. Decoding the Human Genetic and Immunological Basis of COVID-19 mRNA Vaccine-Induced Myocarditis

39. Autoantibodies against type I IFNs in patients with critical influenza pneumonia

40. Live virus neutralization testing in convalescent patients and subjects vaccinated against 19A, 20B, 20I/501Y.V1 and 20H/501Y.V2 isolates of SARS-CoV-2

41. Performance of 11 host biomarkers alone or in combination in the diagnosis of late-onset sepsis in hospitalized neonates: the prospective EMERAUDE study

42. Performance Evaluation of Host Biomarker Combinations for the Diagnosis of Serious Bacterial Infection in Young Febrile Children: A Double-Blind, Multicentre, Observational Study

43. Distinct Immune Reconstitution Profiles Captured by Immune Functional Assays at 6 Months Post Allogeneic Hematopoietic Stem Cell Transplantation

45. Dynamics of viral shedding during ancestral or Omicron BA.1 SARS-CoV-2 infection and enhancement of pre-existing immunity during breakthrough infections

46. Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs

47. Determinants of protection against SARS‐CoV‐2 Omicron BA.1 and Delta infections in fully vaccinated outpatients.

48. Interactions Between Severe Acute Respiratory Syndrome Coronavirus 2 Replication and Major Respiratory Viruses in Human Nasal Epithelium

49. A Simple-to-Perform ifn-γ mRNA Gene Expression Assay on Whole Blood Accurately Appraises Varicella Zoster Virus-Specific Cell-Mediated Immunity After Allogeneic Hematopoietic Stem Cell Transplantation

50. Disappearance of FDG uptake on PET scan after antimicrobial therapy could help for the diagnosis of Coxiella burnetii spondylodiscitis

Catalog

Books, media, physical & digital resources